Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Kiora, Théa Partner for Retinal Disease Treatment
Kiora Pharmaceuticals has joined forces with Théa Open Innovation (TOI), a sister company of Laboratoires Théa, to develop and commercialize KIO-301 for the treatment of degenerative retinal diseases. The strategic agreement grants Théa exclusive worldwide development and commercialization rights, excluding…
UMass Chan Grants Gene Therapy Licenses to Iveric Bio
UMass Chan Medical School has awarded exclusive global rights for the development and commercialization of innovative adeno-associated virus (AAV) gene therapy products targeting Stargardt disease and Leber congenital amaurosis type 10 (LCA10) to Iveric Bio, an Astellas Company. While gene…
Researcher Cautions on Low-Level Red Light for Myopia
A cautionary note has been sounded by a researcher from the University of Houston’s College of Optometry regarding the use of low-level red light (LLRL) therapy for controlling myopia, particularly in children. Despite recent studies touting its effectiveness in reducing…
Reginald J. Sanders, M.D. Named as New President of the ASRS
Dr. Reginald J. Sanders, a distinguished physician affiliated with the Retina Group of Washington (RGW) and PRISM Vision Group, has been named as the new president of the American Society of Retina Specialists (ASRS). Dr. Sanders holds the distinction of…
FDA Approves Modified Axpaxli Trial by Ocular Therapeutix
Ocular Therapeutix announced that the FDA has granted approval for a modification to the special protocol assessment (SPA) agreement for the pivotal phase 3 SOL clinical trial of Axpaxli (axitinib intravitreal implant, also known as OTX-TKI). This modification marks a…
T. Boone Pickens Foundation’s $20M Donation
Founded by the late Texan visionary energy magnate and philanthropist, the T. Boone Pickens Foundation is donating a substantial sum of $20 million to the Wilmer Eye Institute, part of Johns Hopkins Medicine. This significant donation, initially announced in 2013,…
Explained: How Long Is Ophthalmology Residency?
Embarking on a career in ophthalmology involves a meticulous journey of education and training, with the residency period being a critical phase in shaping a future ophthalmologist’s expertise. The duration of an ophthalmology residency is a key consideration for aspiring…
FDA Approval and Funding for ONS-5010
In a significant stride towards advancing its clinical development program for ONS-5010, Outlook Therapeutics has received written agreement from the FDA under a special protocol assessment (SPA) for the NORSE EIGHT clinical trial protocol. This trial aims to evaluate the…
New Study Reveals Insights into Glaucoma in Africans
A team of investigators unveiled previously unknown inherited genetic variants associated with primary open-angle glaucoma (POAG), the most prevalent form of the disease. The study, based on the analysis of 11,275 individuals of African descent, sheds light on the genetic…
OBN Spotlight TV: Interview with Filomena Ribeiro, MD
Ophthalmology Breaking News (OBN) is thrilled to present the first-ever interview with Dr. Filomena Ribeiro as the newly appointed President of the European Society of Cataract and Refractive Surgeons (ESCRS), effective January 1, 2024, succeeding Prof. Oliver Findl. Delve into…